Nucleotide sugar
title: "Nucleotide sugar" type: doc version: 1 created: 2026-02-28 author: "Wikipedia contributors" status: active scope: public tags: ["metabolism", "coenzymes", "carbohydrate-chemistry", "carbohydrates", "nucleotides"] topic_path: "science/chemistry" source: "https://en.wikipedia.org/wiki/Nucleotide_sugar" license: "CC BY-SA 4.0" wikipedia_page_id: 0 wikipedia_revision_id: 0
Nucleotide sugars are the activated forms of monosaccharides. Nucleotide sugars act as glycosyl donors in glycosylation reactions. Those reactions are catalyzed by a group of enzymes called glycosyltransferases.
History
The anabolism of oligosaccharides - and, hence, the role of nucleotide sugars - was not clear until the 1950s when Leloir and his coworkers found that the key enzymes in this process are the glycosyltransferases. These enzymes transfer a glycosyl group from a sugar nucleotide to an acceptor.
Biological importance and energetics
To act as glycosyl donors, those monosaccharides should exist in a highly energetic form. This occurs as a result of a reaction between nucleoside triphosphate (NTP) and glycosyl monophosphate (phosphate at anomeric carbon). The recent discovery of the reversibility of many glycosyltransferase-catalyzed reactions calls into question the designation of sugar nucleotides as 'activated' donors.
::figure[src="https://upload.wikimedia.org/wikipedia/commons/b/bf/activatedmonosaccahride.png" caption="Activation of Monosaccharides"] ::
Types
There are nine sugar nucleotides in humans which act as glycosyl donors and they can be classified depending on the type of the nucleoside forming them:
- Uridine Diphosphate: UDP-α-D-Glc, UDP-α-D-Gal, UDP-α-D-GalNAc, UDP-α-D-GlcNAc, UDP-α-D-GlcA, UDP-α-D-Xyl
- Guanosine Diphosphate: GDP-α-D-Man, GDP-β-L-Fuc.
- Cytidine Monophosphate: CMP-β-D-Neu5Ac; in humans, it is the only nucleotide sugar in the form of nucleotide monophosphate.
- Cytidine Diphosphate: CDP-D-Ribitol (i.e. CMP-[ribitol phosphate]); though not a sugar, the phosphorylated sugar alcohol ribitol phosphate is incorporated into matriglycan as if it were a monosaccharide.
In other forms of life many other sugars are used and various donors are utilized for them. All five of the common nucleosides are used as a base for a nucleotide sugar donor somewhere in nature. As examples, CDP-glucose and TDP-glucose give rise to various other forms of CDP and TDP-sugar donor nucleotides.
Structures
Listed below are the structures of some nucleotide sugars (one example from each type).
::data[format=table]
| UDP-Gal | CMP-Neu5Ac | GDP-Man |
|---|---|---|
| :: |
Relationship to disease
Normal metabolism of nucleotide sugars is very important. Any malfunction in any contributing enzyme will lead to a certain disease Encyclopedia of Biological Chemistry, Volume 2. 2004, Elsevier Inc. Hudson H. Freeze 302-307. for example:
- Inclusion body myopathy: is a congenital disease resulted from altered function of UDP-GlcNAc epimerase .
- Macular corneal dystrophy: is a congenital disease resulted from malfunction of GlcNAc-6-sulfotransferase.
- Congenital disorder in α-1,3 mannosyl transferase will result in a variety of clinical symptoms, e.g. hypotonia, psychomotor retardation, liver fibrosis and various feeding problems.
Relationship to drug discovery
The development of chemoenzymatic strategies to generate large libraries of non-native sugar nucleotides has enabled a process referred to as glycorandomization where these sugar nucleotide libraries serve as donors for permissive glycosyltransferases to afford differential glycosylation of a wide range of pharmaceuticals and complex natural product-based leads.
References
References
- Derek Horton. (2008). "The Development of Carbohydrate Chemistry and Biology". Carbohydrate Chemistry, Biology and Medical Applications.
- (1 September 2006). "Exploiting the reversibility of natural product glycosyltransferase-catalyzed reactions.". Science.
- (27 December 2006). "The in vitro characterization of the iterative avermectin glycosyltransferase AveBI reveals reaction reversibility and sugar nucleotide flexibility.". Journal of the American Chemical Society.
- (5 March 2007). "The in vitro characterization of the erythronolide mycarosyltransferase EryBV and its utility in macrolide diversification.". ChemBioChem.
- (13 October 2008). "The in vitro characterization of polyene glycosyltransferases AmphDI and NysDI.". ChemBioChem.
- (21 August 2011). "Using simple donors to drive the equilibria of glycosyltransferase-catalyzed reactions.". Nature Chemical Biology.
- link. (2011-07-08 Essentials of Glycobiology, Second Edition)
- (2016). "ISPD produces CDP-ribitol used by FKTN and FKRP to transfer ribitol phosphate onto α-dystroglycan". Nature Communications.
- (2003). "Biosynthesis of O-antigens: genes and pathways involved in nucleotide sugar precursor synthesis and O-antigen assembly". Carbohydr. Res..
- (2002). "Formation of unusual sugars: Mechanistic studies and biosynthetic applications". Annu Rev Biochem.
- (November 2005). "Neoglycorandomization and chemoenzymatic glycorandomization: two complementary tools for natural product diversification.". Journal of Natural Products.
- (October 2011). "Enzymatic methods for glyco(diversification/randomization) of drugs and small molecules.". Natural Product Reports.
::callout[type=info title="Wikipedia Source"] This article was imported from Wikipedia and is available under the Creative Commons Attribution-ShareAlike 4.0 License. Content has been adapted to SurfDoc format. Original contributors can be found on the article history page. ::